Lezaić, Visnja D

Link to this page

Authority KeyName Variants
da917a11-9db5-4978-a400-5dc5f815247a
  • Lezaić, Visnja D (1)
Projects
No records found.

Author's Bibliography

Transforming Growth Factor-beta(1) in Balkan Endemic Nephropathy

Đukanović, Ljubica D; Lezaić, Visnja D; Miljković, Đorđe; Momčilović, Miljana; Bukvić, Danica; Marić, Ivko; Miljković, Zeljka; Marinković, Jelena M; Mostarica-Stojković, Marija B

(2009)

TY  - JOUR
AU  - Đukanović, Ljubica D
AU  - Lezaić, Visnja D
AU  - Miljković, Đorđe
AU  - Momčilović, Miljana
AU  - Bukvić, Danica
AU  - Marić, Ivko
AU  - Miljković, Zeljka
AU  - Marinković, Jelena M
AU  - Mostarica-Stojković, Marija B
PY  - 2009
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/1485
AB  - Background/Aim: The aim of this study was to compare plasma and urine transforming growth factor-beta(1) (TGF-beta(1)) levels in patients with different stages of Balkan endemic nephropathy (BEN) with those in patients with primary glomerulonephritis (GN) and healthy controls. Methods: The study involved 47 patients with BEN (30 with manifest BEN and 17 in the early stage of BEN), 12 patients with GN and 10 healthy controls. Plasma and urine TGF-beta(1) was assayed by enzyme-linked immunosorbent assay. Results: The median plasma TGF-beta(1) levels differed nonsignificantly between the groups (4,908-6,442 pg/ml), but individual plasma TGF-beta(1) levels in BEN patients exhibited the highest dispersion. Median urinary TGF-beta(1) excretion (pg/mg creatinine) was significantly higher in patient groups (manifest BEN: 203, early-stage BEN: 341, GN: 775) than in healthy controls (42). No correlation was found between plasma and urine TGF-beta(1) levels or between plasma TGF-beta(1) levels and creatinine clearance for any of the examined groups. Conclusion: Plasma TGF-beta(1) levels in BEN patients extended over the widest range, but no significant differences were found between the median values for the groups. Median urinary TGF-beta(1) excretion was significantly higher in patients with BEN and GN than in healthy controls. Copyright (C) 2009 S. Karger AG, Basel
T2  - Nephron Clinical Practice
T1  - Transforming Growth Factor-beta(1) in Balkan Endemic Nephropathy
IS  - 2
VL  - 111
EP  - C132
UR  - https://hdl.handle.net/21.15107/rcub_ibiss_1485
ER  - 
@article{
author = "Đukanović, Ljubica D and Lezaić, Visnja D and Miljković, Đorđe and Momčilović, Miljana and Bukvić, Danica and Marić, Ivko and Miljković, Zeljka and Marinković, Jelena M and Mostarica-Stojković, Marija B",
year = "2009",
abstract = "Background/Aim: The aim of this study was to compare plasma and urine transforming growth factor-beta(1) (TGF-beta(1)) levels in patients with different stages of Balkan endemic nephropathy (BEN) with those in patients with primary glomerulonephritis (GN) and healthy controls. Methods: The study involved 47 patients with BEN (30 with manifest BEN and 17 in the early stage of BEN), 12 patients with GN and 10 healthy controls. Plasma and urine TGF-beta(1) was assayed by enzyme-linked immunosorbent assay. Results: The median plasma TGF-beta(1) levels differed nonsignificantly between the groups (4,908-6,442 pg/ml), but individual plasma TGF-beta(1) levels in BEN patients exhibited the highest dispersion. Median urinary TGF-beta(1) excretion (pg/mg creatinine) was significantly higher in patient groups (manifest BEN: 203, early-stage BEN: 341, GN: 775) than in healthy controls (42). No correlation was found between plasma and urine TGF-beta(1) levels or between plasma TGF-beta(1) levels and creatinine clearance for any of the examined groups. Conclusion: Plasma TGF-beta(1) levels in BEN patients extended over the widest range, but no significant differences were found between the median values for the groups. Median urinary TGF-beta(1) excretion was significantly higher in patients with BEN and GN than in healthy controls. Copyright (C) 2009 S. Karger AG, Basel",
journal = "Nephron Clinical Practice",
title = "Transforming Growth Factor-beta(1) in Balkan Endemic Nephropathy",
number = "2",
volume = "111",
pages = "C132",
url = "https://hdl.handle.net/21.15107/rcub_ibiss_1485"
}
Đukanović, L. D., Lezaić, V. D., Miljković, Đ., Momčilović, M., Bukvić, D., Marić, I., Miljković, Z., Marinković, J. M.,& Mostarica-Stojković, M. B.. (2009). Transforming Growth Factor-beta(1) in Balkan Endemic Nephropathy. in Nephron Clinical Practice, 111(2).
https://hdl.handle.net/21.15107/rcub_ibiss_1485
Đukanović LD, Lezaić VD, Miljković Đ, Momčilović M, Bukvić D, Marić I, Miljković Z, Marinković JM, Mostarica-Stojković MB. Transforming Growth Factor-beta(1) in Balkan Endemic Nephropathy. in Nephron Clinical Practice. 2009;111(2):null-C132.
https://hdl.handle.net/21.15107/rcub_ibiss_1485 .
Đukanović, Ljubica D, Lezaić, Visnja D, Miljković, Đorđe, Momčilović, Miljana, Bukvić, Danica, Marić, Ivko, Miljković, Zeljka, Marinković, Jelena M, Mostarica-Stojković, Marija B, "Transforming Growth Factor-beta(1) in Balkan Endemic Nephropathy" in Nephron Clinical Practice, 111, no. 2 (2009),
https://hdl.handle.net/21.15107/rcub_ibiss_1485 .